Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Cocklin

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|December 6, 2023
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid ModulatorsShujing Xu, Lin Sun, Michael Barnett, et al.
Journal of Medicinal Chemistry|April 17, 2020
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral ActivitiesLin Sun, Alexej Dick, Megan E Meuser, et al.
Journal of Medicinal Chemistry|April 12, 2008
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1Hosahudya Gopi, M Umashankara, Vanessa Pirrone, et al.
Infection and Immunity|July 16, 2014
An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivoScott M Baliban, Amanda Michael, Berje Shammassian, et al.
European Journal of Medicinal Chemistry|October 15, 2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stabilityShujing Xu, Lin Sun, Alexej Dick, et al.
Biochemistry|March 1, 2011
Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18Syna Kuriakose Gift, Isaac J Zentner, Arne Schön, et al.
Scientific Reports|October 26, 2023
Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Scientific Reports|February 7, 2024
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Frontiers in Pharmacology|May 31, 2024
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cellsEmily M Esquea, Lorela Ciraku, Riley G Young, et al.
Scientific Reports|December 19, 2023
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|December 6, 2023
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid ModulatorsShujing Xu, Lin Sun, Michael Barnett, et al.
Journal of Medicinal Chemistry|April 17, 2020
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral ActivitiesLin Sun, Alexej Dick, Megan E Meuser, et al.
Journal of Medicinal Chemistry|April 12, 2008
Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1Hosahudya Gopi, M Umashankara, Vanessa Pirrone, et al.
Infection and Immunity|July 16, 2014
An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivoScott M Baliban, Amanda Michael, Berje Shammassian, et al.
European Journal of Medicinal Chemistry|October 15, 2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stabilityShujing Xu, Lin Sun, Alexej Dick, et al.
Biochemistry|March 1, 2011
Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18Syna Kuriakose Gift, Isaac J Zentner, Arne Schön, et al.
Scientific Reports|October 26, 2023
Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Scientific Reports|February 7, 2024
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Frontiers in Pharmacology|May 31, 2024
Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cellsEmily M Esquea, Lorela Ciraku, Riley G Young, et al.
Scientific Reports|December 19, 2023
Author Correction: Insights into next generation sequencing guided antibody selection strategiesM Frank Erasmus, Fortunato Ferrara, Sara D'Angelo, et al.
Pageof 8